Impact of SGLT2 Inhibitors on Mortality Risk in Type 2 Diabetes Mellitus and Coronary Artery Disease: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Gonzales, Antony
Collantes-Silva, Nicole
Arambulo-Castillo, Sebastian
Ortiz-Benique, Zhamanda N.
Munoz-Moreno, Juan Manuel
Alarcon, Esteban
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4140060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4140060
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis
    Wong, Hon Jen
    Lin, Norman H.
    Teo, Yao Neng
    Syn, Nicholas L.
    Teo, Yao Hao
    Sia, Ching-Hui
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (03) : 371 - 383
  • [32] EVALUATION OF THE LIFETIME BENEFITS OF METFORMIN AND SGLT2 INHIBITORS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW AND TWO-STAGE META-ANALYSIS
    Lin, Norman
    Wong, Hon Jen
    Teo, Yao Neng
    Syn, Nicholas
    Teo, Yao Hao
    Sia, Ching Hui
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1972 - 1972
  • [33] Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Shi-di Zhao
    Ling Zhou
    Yi-ying Tao
    Yue Yue
    Jia-xin Wang
    Lei Shen
    Guo-yuan Lu
    Yong-fu Hang
    International Journal of Diabetes in Developing Countries, 2022, 42 : 178 - 190
  • [34] Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
    Yang, Shiwen
    Liu, Ying
    Zhang, Shengzhao
    Wu, Fengbo
    Liu, Dan
    Wu, Qingfang
    Zheng, Hanrui
    Fan, Ping
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [35] Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Zhao, Shi-di
    Zhou, Ling
    Tao, Yi-ying
    Yue, Yue
    Wang, Jia-xin
    Shen, Lei
    Lu, Guo-yuan
    Hang, Yong-fu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 178 - 190
  • [36] Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease
    Chipayo Gonzales, D. A.
    Salinas, P.
    Fuentes, M.
    Vergara, C.
    Espejo-Paeres, C.
    McInerney, A.
    Tirado-Conte, G.
    Macaya-Ten, F.
    Mejia-Renteria, H.
    Nunez-Gil, I.
    Gonzalo, N.
    Jimenez-Quevedo, P.
    Nombela-Franco, L.
    Escaned, J.
    Fernandez-Ortiz, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2690 - 2690
  • [37] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Wen-jie Li
    Xing-qing Chen
    Ling-ling Xu
    Yuan-qing Li
    Bi-hui Luo
    Cardiovascular Diabetology, 19
  • [38] SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis
    Kanbay, Mehmet
    Brinza, Crischentian
    Copur, Sidar
    Sekreter, Ozge
    Burlacu, Alexandru
    Tuttle, Katherine R.
    Rossing, Peter
    Covic, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
  • [39] Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
    Hegde, Naveen C.
    Kumar, Ankit
    Patil, Amol N.
    Bhattacharjee, Samiksha
    Gamad, Nanda
    Kasudhan, Kripa Shanker
    Kumar, Vivek
    Rastogi, Ashu
    ACTA DIABETOLOGICA, 2023, 60 (10) : 1311 - 1331
  • [40] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Li, Wen-jie
    Chen, Xing-qing
    Xu, Ling-ling
    Li, Yuan-qing
    Luo, Bi-hui
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
12345